XML 51 R40.htm IDEA: XBRL DOCUMENT v3.5.0.2
Business combination - Pro Forma Impact of Business Combination (Details) - ARIAD Pharmaceuticals - USD ($)
$ in Thousands
3 Months Ended 4 Months Ended 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2016
Sep. 30, 2016
Sep. 30, 2015
Unaudited pro forma information          
Acquisition-Related Costs $ 1,500     $ 1,500  
Revenue of ARIAD     $ 16,700    
Net loss of ARIAD     $ (28,200)    
Pro forma net sales 269,469 $ 194,866   821,743 $ 528,711
Pro forma net income (loss) 36,877 $ (48,613)   91,248 $ (96,015)
Revenue that had been deferred $ 24,400     $ 24,400